E-ISSN 2602-3164

Real World Outcomes of First Line Pertuzumab Based Therapy in HER2 Positive Metastatic Breast Cancer: Performance Status, Metastatic Burden and Nutritional Status as Prognostic Factors

EJMI & EJMI